• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Skin Microbiota
      • Anti-oxidant
        • Oxidative stress
        • Lipid peroxidation
        • Glutathione Stock
      • Wound Healing
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us ?
    • Subscribe to our Newsletter

services

News

Agrément CIR jusqu’en 2023 pour HCS Pharma

Nous sommes heureux de vous annoncer que le Ministère de l’Enseignement Supérieur et de la Recherche a accordé à HCS Pharma l’agrément au Crédit d’Impôt Recherche (CIR) jusqu’en 2023, en regard de nos activités de R&D. For non-french readers, the CIR (Research Tax Credit) concept is explain here. Our customers can Read more…

By Elodie Vandenhaute, 2 months2 months ago
News

Feedback from NutrEvent 2019 in Rennes

Last week, our study director Elodie was in Rennes to participate in NutrEvent! We had a booth there, under NSL Clubster pavilion (Lille Northern France Health and Nutrition clubster). It was a pleasure for her to present our activities in imaging and our 3D cell culture products to the visitors! Read more…

By Elodie Vandenhaute, 1 year4 months ago
News

We are happy to join Science Exchange platform

You should know Science Exchange, the world’s leading and most secure platform for outsourced research, providing large R&D organizations with the fastest path from discovery through development and commercialization. Now, we are very proud to provide our most innovative services on the platform! We will find: 3D Cell Culture Models Read more…

By Grégory MAUBON, 2 years4 months ago
News

We’ll be at HI Europe in Frankfurt, Germany!

Our study directors Elodie and Pierre-Jean will attend “HI Europe” in Frankfurt next week. We cordially invite you to discuss with them, they will be happy to present our imaging services related to nutraceutical testing! We are equipped to test from one to thousands of ingredients on any of our state-of-the-art Read more…

By Elodie Vandenhaute, 2 years4 months ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • The importance of extracellular matrix in cancers
  • Webinar “Applications for 3D in vitro models with BIOMIMESYS® Adipose Tissue and preview of future BIOMIMESYS® Skin” (April 20 & 22)
  • Lucille joins us to develop hepatocellular models and hiPSCs-derived liver organoids
  • Our next webinar with Molecular Devices : A physiologically-relevant 3D ECM for in vitro oncology research and intelligent high-content imaging of 3D models
  • In silico drug development: a perfect supplement to our in vitro 3D BIOMIMESYS technology
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell CHOPIN congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix forum labo genotoxicity HCA HCS hcs pharma High content screening hyaluronic acid imaging innovation in vitro liver meeting Microbiota microenvironment microscopy model Molecular Devices NEUROCELL3D neurotoxicity oncology Parkinson phenotypic screening picture rennes screening skin toxicology
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress